scholarly journals Percutaneous Ethanol Injection in Combination with Laser Ablation for a 100 ml Partially Cystic Thyroid Nodule

2018 ◽  
Vol 2018 ◽  
pp. 1-3
Author(s):  
Roberto Negro ◽  
Gabriele Greco

Until nonsurgical techniques like laser ablation (LA) or radiofrequency became available, patients suffering from large nodules with compressive symptoms were addressed to surgery. We describe the case of a 59-year-old woman with a large, partially cystic thyroid nodule having a volume of about 100 ml. As the patient refused surgery, despite her constant local discomfort, such large partially cystic nodule underwent several percutaneous ethanol injections (PEI) and then was submitted to LA. The combination of these two procedures allowed firstly complete disappearance of the cystic component and secondly a significant reduction of thyroid nodule, which finally measured 17 ml in volume (82% reduction compared to baseline). This case demonstrates that even in very large partially cystic nodules LA preceded by PEI represents a valid alternative to surgery.

Thyroid ◽  
2012 ◽  
Vol 22 (2) ◽  
pp. 210-213 ◽  
Author(s):  
Concetto Regalbuto ◽  
Rosario Le Moli ◽  
Vincenzo Muscia ◽  
Marco Russo ◽  
Riccardo Vigneri ◽  
...  

Thyroid ◽  
1997 ◽  
Vol 7 (5) ◽  
pp. 699-704 ◽  
Author(s):  
NADIA CARACCIO ◽  
ORLANDO GOLETTI ◽  
PIERO VINCENZO LIPPOLIS ◽  
ARTURO CASOLARO ◽  
ENRICO CAVINA ◽  
...  

Thyroid ◽  
1995 ◽  
Vol 5 (6) ◽  
pp. 473-475 ◽  
Author(s):  
DONATELLA CORTELAZZI ◽  
DANIELA CASTAGNONE ◽  
BEATRICE TASSIS ◽  
ELISABETTA VENEGONI ◽  
ROBERTO RIVOLTA ◽  
...  

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A896-A897
Author(s):  
Marlen Alejandra Alvarez Castillo ◽  
Antonio Segovia Palomo

Abstract Introduction: Differentiated thyroid cancer (DTC) presents central lymph node metastasis in 20-50% and lateral in 12-86% of patients, the treatment of choice is surgical reintervention but it carries a higher risk of complications secondary to fibrosis formation in the surgical bed. Alternative nonsurgical therapies such as percutaneous ethanol injection (PEI), radiofrequency or laser ablation have been described. Objective: To report a case of oligometastasis in CDT which underwent percutaneous polidocanol injection (PPI). Clinical Case: A 35-year-old female who underwent a total thyroidectomy in 06-2019 for papillary thyroid cancer (AJCC: stage I/ ATA: intermediate risk), and ablative dose of 150 mCi I131, under treatment with levothyroxine 150 mcg/d. Hospitalized 02-2020 for progressive dysphonia of 2 months of evolution, with studies of TSH 0.04 mIU/ml, TgAb 13 IU/ml, Tg 0.5 ng/ml and neck USG: right lymph node level III of 0.97 cm in short axis, suspected of malignancy. Tg washout 4743.72 ng/ml (positive), 1cc of 1% polidocanol is administered, guided by USG. 7 days later with 0.90 cm in short axis, a second dose of 1% polidocanol was administered and a new Tg washout was taken, 2.4 ng/ml (indeterminate). She was reevaluated in the first and fourth months of the procedure, with 0.10 cm in the short axis and complete disappearance of the lesion, respectively. Control studies at the fourth month of TgAb 13 IU/ml, Tg 0.4 ng/ml. Discussion: PEI is described for thyroid cysts and adenomas and for cervical lymph node metastases, this is a minimally invasive procedure in the treatment of lesions smaller than 10 mm but requires multiple sessions and it can cause pain due to extravasation, skin necrosis and damage to the recurrent laryngeal nerve. It requires a follow-up time of up to 65 months, producing a reduction in serum Tg less than 2.4 ng/ml, a decrease in the size of the lesion and disappearance in 46% of the cases. In our center we have experience with PPI in thyroid cysts and adenomas since 2017, this requires fewer sessions and a lower dose, obtaining results of volume reduction in thyroid cysts of 80%. In this case we observed a reduction of 90% in the first month and disappearance in the fourth month, with a significant decrease in Tg washout from the first administration. Conclusion: Polidocanol is safe and effective so it should be considered in the treatment of oligometastasis in DTC.


2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A873-A873
Author(s):  
Arjun Baidya ◽  
Saba Faiz ◽  
Ram Chandra Bhadra

Abstract Introduction: Ultrasound guided percutaneous ethanol injection (PEI) of benign thyroid nodule is an easy and effective procedure particularly in cystic and predominantly cystic nodule. Aims: To evaluate efficacy and safety of PEI in managing purely cystic and mixed cystic and solid thyroid nodules. Materials and Methods: Patients of either sex presented with solitary purely cystic benign thyroid nodule, solitary benign mixed with predominantly cystic (>50% of total volume) thyroid nodule, solitary benign mixed with predominantly solid (>50% of total volume) thyroid nodule, solitary solid thyroid nodule were included in this study. Patients who had a nodule BETHESDA 3 and above, pregnancy, patients with critical or terminal illness, patients with other malignancies, multinodular lesions of thyroid, patients with raised T3, T4 and/ or suppressed TSH level were excluded from the study. One hundred sixty patients presenting with thyroid nodule were initially evaluated with thyroid function test and USG. Only those patients with euthyroid solitary thyroid nodules are subjected for fine needle aspiration (FNA). Nodules under BETHESDA 2 are considered for US guided percutaneous ethanol injection (PEI). One hundred twenty-three patients were excluded because of various reasons. Finally ethanol ablation was done in 37 patients. Benign, purely cystic and mixed thyroid nodules were aspirated under ultrasonography guidance. Sterile absolute alcohol (99.99%) (50% of volume aspirated/ maximum 10 ml) was injected and reviewed after 2, 5and 7 months. In case of solid nodule alcohol (50% of nodule volume) was injected. A reduction in volume is calculated at each follow up visit. An adequate response is considered as ≥50 percent reduction in size from baseline after 7 months. If the reduction is <50%, then a second session of absolute ethanol injection is given. Again, patients were similarly followed up after 2, 5 and 7 months. Results: Thirty seven patients underwent PEI. Thirty three patients were considered for final analysis (4 lost to follow up). Response rate of PEI for purely cystic nodule was 100.0% and the overall response rate for mixed nodule was 53.57%. None of the solid nodule responded to PEI even after second session. Among the responder in the mixed nodules, 93.33% responded after first session of PEI. Minor complications like headache occurred in 54.1% patients in the first session. Transient pain at injection site were complained by 86.5% and 37.8% patients in the first and second session respectively. Nausea and vomiting were complained by 18.9% and 16.2% patients in the first and second session respectively. Conclusions: PEI is an effective and safe for purely cystic and mixed thyroid nodules. It is a relatively safe and less invasive procedure from management of benign solitary cystic and mixed thyroid nodules.


1996 ◽  
Vol 10 (2) ◽  
pp. 171-176 ◽  
Author(s):  
Kunihiro Nakada ◽  
Chietsugu Katoh ◽  
Kakuko Kanegae ◽  
Eriko Tsukamoto ◽  
Kazuo Itoh ◽  
...  

2009 ◽  
Vol 53 (3) ◽  
pp. 292-296
Author(s):  
Vincenzo Nirchio ◽  
Francesco Nirchio ◽  
Umberto Crocetti ◽  
Paola Tizzani ◽  
Vincenzo Trischitta ◽  
...  

The Lancet ◽  
1991 ◽  
Vol 337 (8743) ◽  
pp. 743 ◽  
Author(s):  
Fabio Monzani ◽  
Orlando Goletti ◽  
Ferdinando De Negri ◽  
Paolo Del Guerra ◽  
Piero Vincenzo Lippolis ◽  
...  

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A947-A947
Author(s):  
Paola Rios ◽  
Jonathan Ambut ◽  
Alex Manzano

Abstract Background: Thyroid cystic nodules are common and frequently benign. Aspiration of thyroid cyst decreases compression symptoms and volume. However, they commonly recur, and usually, surgery is required for definitive treatment. A less invasive approach, done less frequent, is percutaneous ethanol injection (PEI), which has shown fewer recurrences than simple aspiration and is well-tolerated with few side effects. We present 2 patients that where treated in our clinic with PEI. Clinical Case: 41-year-old female with a history of primary hypothyroidism on Levothyroxine, with neck discomfort, and no risk factors for thyroid cancer had a cystic thyroid nodule 1.5 x 1.8 x 2.8 cm over the right thyroid lobule. Cytology results reported as Bethesda II. One year later, her thyroid nodule was 1.9 x 2.6 x 3.3 cm. Underwent FNA and 6 cc of dark brown liquid was drained from the cyst which was reported again as Bethesda II. The patient was monitored with thyroid ultrasound after a year, and the cystic nodule was 2.2 x 2.9 x 3.1 cm. PEI was decided as the next approach. After six cc was aspired, 0.5 cc of desiccated ethanol was injected into the remained cystic. Eight months after PEI, cystic size was 0.7 x 0.9 x 0.8 cm. The second case is a 40-year-old female who presented complaining of neck discomfort without changes in her voice. The patient did not have any risk factors for thyroid cancer. Thyroid ultrasound was done, which showed a 2.3 x 2.7 x 3.3 cm cyst on her right thyroid lobe. PEI was arranged and 9 cc of dark fluid was aspirated with a posterior injection of 0.5 cc of desiccated ethanol. Symptoms resolved, and the patient was lost to follow up. Five years later, she was seen again. Neck ultrasound showed a cyst of 0.4 x 0.6 x 0.8 cm on her right thyroid lobe. Neither of the two patients had a side effect associated, and the procedure was well tolerated. Conclusions: Percutaneous ethanol injection is a good alternative in the treatment for cystic thyroid nodules due to decrease in cystic size, which we observed that continued for five years of follow up in one of our patients. These will avoid frequent cystic aspiration secondary to recurrence or invasive surgical management.


Sign in / Sign up

Export Citation Format

Share Document